Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income and Growth VCT 2 Regulatory News (MIG2)

Share Price Information for Maven Income and Growth VCT 2 (MIG2)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
MIG2 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income and Growth VCT 2 Share Chart

Form 8.3 - Work Group PLC

25 Jul 2017 12:55

RNS Number : 0414M
Maven Capital Partners
25 July 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Maven Capital Partners UK LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Maven Income and Growth VCT 2 PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC, Maven Income and Growth VCT 6 PLC

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Work Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25 July 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

874,357

3.13

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

874,357

3.13

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

25 July 2017

Contact name:

Graeme Cullen

Telephone number:

0141 206 0110

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETFELFLDDFEBBZ
Date   Source Headline
15th Nov 20183:13 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
15th Nov 201812:09 pmRNSResult of Second General Meeting
15th Nov 20187:30 amRNSSuspension- Maven Income and Growth VCT 2 PLC
15th Nov 20187:30 amRNSSuspension of Trading
1st Nov 201812:23 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
13th Sep 20186:16 pmRNSPossible Merger
12th Sep 20181:45 pmRNSNet Asset Value(s)
21st Jun 20183:33 pmRNSTransaction in Own Shares
13th Jun 201812:46 pmRNSNet Asset Value(s)
13th Jun 201812:45 pmRNSResult of AGM
17th May 20184:30 pmRNSDividend Declaration
11th May 20184:05 pmRNSAnnual Financial Report
16th Mar 20184:52 pmRNSNet Asset Value(s)
22nd Dec 201710:47 amRNSDividend Declaration
8th Dec 201712:44 pmRNSNet Asset Value(s)
19th Oct 20174:52 pmRNSTransaction in Own Shares
5th Oct 20174:51 pmRNSTransaction in Own Shares
29th Sep 20177:00 amRNSHalf-year Report
18th Sep 20173:39 pmRNSNet Asset Value(s)
17th Aug 20174:09 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
14th Jun 20171:56 pmRNSNet Asset Value and Final Dividend
14th Jun 20171:43 pmRNSResult of AGM
12th May 20174:32 pmRNSAnnual Financial Report
6th Apr 20173:59 pmRNSNet Asset Value and Proposed Final Dividend
20th Jan 20174:47 pmRNSTransaction in Own Shares
8th Dec 201612:09 pmRNSNet Asset Value(s)
23rd Sep 20169:55 amRNSHalf-year Report
15th Sep 20163:38 pmRNSDirector/PDMR Shareholding
13th Sep 20162:52 pmRNSStatement re NAV & Dividend
6th Jul 20164:43 pmRNSTransaction in Own Shares
15th Jun 201612:29 pmRNSNet Asset Value(s)
15th Jun 201612:27 pmRNSResult of AGM
6th May 20163:56 pmRNSAnnual Financial Report
11th Apr 20164:56 pmRNSTransaction in Own Shares
30th Mar 20162:45 pmRNSNet Asset Value and Proposed Final Dividend
10th Feb 20163:39 pmRNSForm 8.3 - Tangent Communications PLC
9th Dec 20154:17 pmRNSPortfolio Update and Unaudited Net Asset Value
30th Sep 201512:33 pmRNSHalf Yearly Report
24th Sep 20151:36 pmRNSStatement re NAV and Dividend Payments
16th Sep 20152:28 pmRNSDirectorate Change
4th Sep 201510:50 amRNSPortfolio Update
24th Aug 20153:36 pmRNSStatement re Dividend Investment Scheme
2nd Jul 20152:36 pmRNSDirector/PDMR Shareholding
26th Jun 201512:40 pmRNSIssue of Equity
26th Jun 20159:38 amRNSNet Asset Value(s)
24th Jun 20154:42 pmRNSDirector/PDMR Shareholding
17th Jun 20151:08 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.